Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

about

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

Item

http://www.wikidata.org/entity/Q57300052

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@en

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@nl

type

Item

label

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@en

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@nl

prefLabel

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@en

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@nl

P1476

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease

@en

P2093

Chiara Baggio

http://www.w3.org/2001/XMLSchema#string

Francesca Oliviero

http://www.w3.org/2001/XMLSchema#string

Paola Galozzi

http://www.w3.org/2001/XMLSchema#string

Sara Bindoli

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Canakinumab

Preclinical characterization and clinical development of ILARIS(®) (canakinumab) for the treatment of autoinflammatory diseases

Anti-Interleukin-1 Agents in Adult Onset Still's Disease

Structural insights into the assembly and activation of IL-1β with its receptors

Structure of the activating IL-1 receptor signaling complex

One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β

X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution

The interleukin 1 receptor: ligand interactions and signal transduction

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

P304

1074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01074

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Sfriso

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30298010

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6160871

http://www.w3.org/2001/XMLSchema#string